New AI-generated COVID drug enters Phase I clinical trials: ‘Effective against all variants’

Insilico Medicine, an AI-driven biotech company, has developed an AI-designed drug for COVID-19 that has entered Phase I clinical trials, offering a potential alternative to the current medication Paxlovid with improved effectiveness against variants and easier production.

foxnews.com

Relevant topic timeline:

8/23/2023

Understanding mergers between hospitals and health systems in different markets

### Summary Recent research shows that Paxlovid is a "game changer" in the treatment of COVID-19, with solid data on its effectiveness. HCA has announced a new operational and leadership structure designed to align with the company's strategy. Phoenix Children's Hospital is rising to the challenge of clinician recruitment and retention. In response to complaints, the DEA is revising its guidelines for prescribing controlled substances via telemedicine.

9/6/2023

Fox News AI Newsletter: Artificial intelligence-generated COVID drug enters clinical trials

An AI-generated COVID drug enters clinical trials, GM and Google strengthen their AI partnership, and Israel unveils an advanced AI-powered surveillance plane, among other AI technology advancements.

9/22/2023

AI Speeds Up Patient Recruitment and Reduces Costs of Clinical Drug Trials

Major drugmakers are using artificial intelligence (AI) to accelerate drug development by quickly finding patients for clinical trials and reducing the number of participants needed, potentially saving millions of dollars. AI is increasingly playing a substantial role in human drug trials, with companies such as Amgen, Bayer, and Novartis using AI tools to scan vast amounts of medical data and identify suitable trial patients, significantly reducing the time and cost of recruitment. The use of AI in drug development is on the rise, with the US FDA receiving over 300 applications that incorporate AI or machine learning in drug development from 2016 through 2022.

Topics

Posted 9/5/2023, 6:00:00 AM